Esomeprazole Once Daily for 6 Months Is Effective Therapy for Maintaining Healed Erosive Esophagitis and for Controlling Gastroesophageal Reflux Disease Symptoms: A Randomized, Double-Blind, Placebo-Controlled Study of Efficacy and Safety

Johnson, David A.; Benjamin, Stanley B.; Vakil, Nimish B.; Goldstein, Jay L.; Lamet, Mark; Whipple, James; D'Amico, Donald; Hamelin, Bernard
January 2001
American Journal of Gastroenterology;Jan2001, Vol. 96 Issue 1, p27
Academic Journal
OBJECTIVE: Esomeprazole. the S-isomer of omeprazole, achieves a significantly greater healing rate and symptom resolution of erosive esophagitis than that achieved by omeprazole. The objective of this study is to assess the efficacy of the new proton pump inhibitor esomeprazole in preventing relapse over a prolonged period in patients with healed erosive esophagitis. METHODS: A total of 318 gastroesophageal reflux patients whose erosive esophagitis was healed in a comparative study of esomeprazole 40 mg, 20 mg, or omeprazole 20 mg, were randomized to maintenance therapy with once daily esomeprazole 40 mg, 20 mg, or 10 mg, or placebo in a U.S., double-blind multicenter trial. RESULTS: After 6 months, healing was maintained (cumulative life table rates) in 93.6% (95% CI 87.4-99,7) of patients treated with esomeprazole 40 mg, 93.2% (93% CI 87.4-99.0) treated with esomeprazole 20 mg, and 57.1% (95% CI 45.2-69) treated with esomeprazole 10 mg; p > 0.001 vs placebo (29.1%; 95% CI 17.7-40.3), Of patients relapsing, mean time to first recurrence of esophagitis increased with dose, from 34 days (placebo) to 78 days (10 mg), 115 days (20 mg), and 163 days (40 mg). Patients treated with esomeprazole had less frequent and less severe heartburn than those treated with placebo. At month 6, more than 70% of patients being treated with esomeprazole remained symptom-free, CONCLUSIONS: Esomeprazole is effective and well tolerated in the maintenance of a healing erosive esophagitis. Esomeprazole 40 mg and 20 mg maintain healing in over 90% of patients while providing effective control of heartburn symptoms.


Related Articles

  • Omeprazole maintenance therapy for GERD. Parks, Susan Mockus // Journal of Family Practice;Oct97, Vol. 45 Issue 4, p292 

    The article discusses research being done on the effectiveness of omeprazole maintenance therapy on gastroesophageal reflux disease (GERD). It references a study by T. L. Venables, R. D. Newland, A. C. Patel, J. Hole, M. B. Copeman and M. L. Turbitt published in the 1997 issue of "Scandinavian...

  • Are Proton Pump Inhibitors Useful in Infants with Reflux? Sadovsky, Richard // American Family Physician;2/15/2004, Vol. 69 Issue 4, p973 

    Discusses research being done on the efficacy of omeprazole in infants with gastroesophageal reflux disease (GERD). Reference to the studies by D.J. Moore et al and P.E. Putnam published in the August 2003 issue of the "Journal of Pediatrics"; Treatment used for infants with GERD; Rate of...

  • Sucralfate Maintenance Therapy in Reflux Esophagitis. Tytgat, G. N. J.; Koelz, H.-R.; Vosmaer, G. D. C. // American Journal of Gastroenterology;Aug1995, Vol. 90 Issue 8, p1233 

    Objective: to prove in a double-blind placebo-controlled multinational trial the effects of sucralfate suspension 2 g BID and placebo in the prevention of recurrent reflux esophagitis. Methods: One hundred and eighty-four patients from 16 centers with reflux esophagitis Savary grade 1 and 2 were...

  • esomeprazole.  // Davis's Drug Guide for Nurses, 10th edition;2007, p479 

    The article presents a nursing guide to esomeprazole, an antiulcer agent for the treatment of GERD, including erosive esophagitis, among others. Its mechanism of action and pharmacokinetics are explained. Contraindications for the drug are presented. Its adverse reactions are cited. Nursing...

  • Dexlansoprazole MR in the Management of Gastroesophageal Reflux Disease. Olsen, Keith M.; Hitzeman, Margaret L. // Clinical Medicine: Therapeutics;2009, Issue 1, p1641 

    Dexlansoprazole MR, an enantiomer of lansoprazole, is a unique proton pump inhibitor with a duel release mechanism. This release mechanism produces two distinct peak concentrations that result in a prolonged mean residence time with increased duration of plasma concentrations and a greater...

  • Natural Course of Gastroesophageal Reflux Disease: 17-22 Year Follow-Up of 60 Patients. Isolauri, Jouko; Luostarinen, Markku; Isolauri, Erika; Reinikainen, Pekka; Viljakka, Mikko; Keyriläinen, Olavi // American Journal of Gastroenterology;Jan1997, Vol. 92 Issue 1, p37 

    Objective: To elucidate the long-term course of conservatively managed gastroesophageal reflux disease without H2-antagonists or omeprazole. Methods: Design: Clinical trial, uncontrolled. Setting: Gastroenterological outpatient department of a teaching hospital. Patients: Sixty of 87 patients...

  • A Prospective Evaluation of Esophageal Testing and a Double-Blind, Randomized Study of Omeprazole in a Diagnostic and Therapeutic Algorithm for Chronic Cough. Ours, Tina M.; Kavuru, Mani S.; Schilz, Robert J.; Richter, Joel E. // American Journal of Gastroenterology;Nov1999, Vol. 94 Issue 11, p3131 

    OBJECTIVE: Recent studies suggest an association between chronic cough and gastroesophageal reflux. Our study aims were 1) to define the prevalence of acid reflux induced cough in the general community, 2) to examine the ability of esophageal testing to identify gastroesophageal reflux related...

  • OMEPRAZOLE OR RANITIDINE FOR INTERMITTENT TREATMENT OF GERD? Salzberg, Sarah A.; Newton, Warren P. // Journal of Family Practice;May99, Vol. 48 Issue 5, p332 

    The article presents information on a study that examines the suitability of using omeprazole or ranitidine for the intermittent treatment of gastroesophageal reflux disease (GERD). GERD is a common diagnosis in primary care, but optimal management is not well defined. Continuous treatment with...

  • Effect of Omeprazole and High Doses of Ranitidine on Gastric Acidity and Gastroesophageal Reflux in Patients with Moderate-Severe Esophagitis. Fiorucci, Stefano; Santucci, Luca; Morelli, Antonio // American Journal of Gastroenterology;Nov1990, Vol. 85 Issue 11, p1458 

    Thirty to fifty percent of patients with reflux esophagitis fail to heal after treatment with conventional doses of 112-receptor antagonists, whereas omeprazole administration induces more than 90% healing. To investigate the effect of omeprazole and higher-than-presently-recommended doses of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics